Objective Assessment of patient preference for antipsoriatic treatment with
calcipotriol ointment or short-contact dithranol cream.
Methods Two hundred and fifty-eight psoriatic patients treated with calcipo
triol (n = 138) or dithranol (n = 120) for up to 3 months, assessed the acc
eptability of treatment, overall satisfaction with treatment, their treatme
nt preference using the 'willingness to pay' principle and selected their t
reatment of choice.
Results Overall satisfaction with calcipotriol was significantly better (72
.7%, dithranol 60.3%; odds ratio 1.75, 95% CI 1.03, 2.99: P = 0.04). Patien
ts considered calcipotriol a more acceptable treatment than dithranol in it
s appearance, smell, non-irritancy, method and ease of application and lack
of staining. Dithranol was considered less sticky than calcipotriol. Patie
nts were 'willing to pay' a mean of pound 12.16 monthly for calcipotriol an
d pound 10.66 monthly for dithranol. 'Willingness to pay' did not correlate
well with overall treatment satisfaction and was not correlated with house
hold income. Calcipotriol was the preferred treatment of choice (calcipotri
ol 63%, dithranol 24%).
Conclusion Patients with psoriasis prefer treatment with calcipotriol ointm
ent over short-contact dithranol cream.